Cornerstone Investment Partners, LLC - AMPHASTAR PHARMACEUTICALS IN ownership

AMPHASTAR PHARMACEUTICALS IN's ticker is AMPH and the CUSIP is 03209R103. A total of 214 filers reported holding AMPHASTAR PHARMACEUTICALS IN in Q4 2022. The put-call ratio across all filers is 0.20 and the average weighting 0.1%.

Quarter-by-quarter ownership
Cornerstone Investment Partners, LLC ownership history of AMPHASTAR PHARMACEUTICALS IN
ValueSharesWeighting
Q2 2024$338,200
-15.8%
8,455
-7.5%
0.02%
-15.0%
Q1 2024$401,557
-29.0%
9,1450.0%0.02%
-37.5%
Q4 2023$565,618
+34.5%
9,1450.0%0.03%
+23.1%
Q3 2023$420,579
-25.4%
9,145
-6.8%
0.03%
-25.7%
Q2 2023$563,953
+53.3%
9,8130.0%0.04%
+45.8%
Q1 2023$367,987
+16.2%
9,813
-13.2%
0.02%
+20.0%
Q4 2022$316,626
-5.2%
11,300
-5.0%
0.02%
-16.7%
Q3 2022$334,000
-19.3%
11,9000.0%0.02%
-14.3%
Q2 2022$414,000
-4.2%
11,900
-1.2%
0.03%
+12.0%
Q1 2022$432,000
+54.3%
12,045
+0.1%
0.02%
+56.2%
Q4 2021$280,00012,0290.02%
Other shareholders
AMPHASTAR PHARMACEUTICALS IN shareholders Q4 2022
NameSharesValueWeighting ↓
MQS Management LLC 10,935$255,0000.41%
GLOBEFLEX CAPITAL L P 144,692$3,370,0000.34%
CORNERCAP INVESTMENT COUNSEL INC 58,975$1,374,0000.20%
Factorial Partners, LLC 10,900$254,0000.17%
FEDERATED HERMES, INC. 3,464,335$80,684,0000.15%
Campbell & CO Investment Adviser LLC 14,800$345,0000.12%
FULLER & THALER ASSET MANAGEMENT, INC. 611,462$14,241,0000.08%
Summit Global Investments 45,900$1,069,0000.07%
RENAISSANCE GROUP LLC 63,559$1,480,0000.06%
PDT Partners, LLC 33,459$779,0000.06%
View complete list of AMPHASTAR PHARMACEUTICALS IN shareholders